NHS under pressure, Breast cancer prevention, Lactose intolerance
Inside Health
BBC
4.4 • 575 Ratings
🗓️ 17 January 2017
⏱️ 29 minutes
🧾️ Download transcript
Summary
Do funding requests hinder surgery on the NHS? GP referrals to specialists for common complaints are checked by a panel to make sure they're appropriate, but can the admin for funding requests be more costly and time consuming than the operation itself? Mark Porter meets an eye specialist in Reading who argues that it can. Plus a new genetic test that has been developed to identify women at risk of breast cancer more accurately. And lactose intolerance: there's a burgeoning number of lactose-free ads and products in the shops, but is need driving the market - or marketing driving the need?
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Hello, I'm Greg Jenna and good news, Your Dead to Me is back for a new series. Here we go. Yes, we'll explore Emperor Nero's notorious reign with Professor Marybeard and Patton Oswald. I would not want my daughter having the remote control, not alone an empire. We'll dissect the decadent life of Philippe Duke-Dor-Leon with Tom Allen. I've often tried to pretend I'm an aristocrat and being very quickly knocked down. And there'll be so much more with comedians like Olga Koch, Mike Mosniak and Rihalina. I'm excited. You're dead to me, the comedy podcast that takes history seriously. Listen first on BBC Sounds. Hello, thank you for listening to this edition of Inside Health. I hope you enjoy it. Coming up today, lactose intolerance. If you believe the ads and the glossy mags, |
| 0:42.2 | lactose appears to be the latest nutrient to avoid if you're prone to rumbly guts and feeling a bit under the weather. |
| 0:49.1 | But what does the science say? And preventing breast cancer. |
| 0:53.2 | Nice already advocates offering preventive drugs like |
| 0:55.9 | Tamoxifen to women most likely to develop the disease. But how should we identify them? |
| 1:01.6 | I meet the man behind a new, more accurate method. If you went to your doctor and they said |
| 1:06.2 | you're at high risk of a heart attack, come back in a year and we'll see if you've had one. |
| 1:09.4 | You wouldn't be too happy. But that's in fact what we do in breast cancer now. |
| 1:13.3 | More on breast cancer prevention later, but first a subject that's likely to touch most families |
| 1:18.4 | at some stage. We all know the NHS is under pressure. It's hard to miss it at the moment. |
| 1:23.6 | Rising demand and finite resources mean it's had to cut its cloth accordingly and limit the treatments it offers. |
| 1:30.4 | One way to do that is to scrutinise all GP referrals to specialists to check that they're appropriate and for conditions that the NHS is happy to fund. |
| 1:40.3 | Such third-party scusionee made the headlines this week following concerns that it may slow down care for some cancer patients. |
| 1:47.7 | But the repercussions affect far more common and less sinister complaints too. |
| 1:52.7 | Complaints like bunions, varicrous veins and hernias, all of which are often no longer eligible for surgical treatment on the NHS in many parts of the UK. |
| 2:01.6 | And those three are just the tip of a growing iceberg, |
| 2:04.6 | as the bar for eligibility for care is raised ever higher in an attempt to rationalise services. |
| 2:10.4 | Dr Margaret McClartney is in our Glasgow studio. |
| 2:12.9 | Margaret, let's start with the GP's referral. |
| 2:15.8 | Who's checking that? |
| 2:17.3 | Well, it depends where you live. So in some |
| 2:19.3 | areas, referrals like this may go to a private company working outside the NHS but contracted |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from BBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of BBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

